Optimizing Open Label Placebo Rationales
NCT05952960 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11
Last updated 2025-07-28
Summary
A 3-arm randomized trial where all chronic pain patients will receive honest placebos, but the information about the placebos will differ between conditions. Outcomes are measured for 21 days and a qualitative survey will be conducted.
Conditions
Interventions
- OTHER
-
Placebo
Open Label Placebo + Rationale
Sponsors & Collaborators
-
Rhode Island Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-07-15
- Primary Completion
- 2023-12-31
- Completion
- 2023-12-31
Countries
- United States
Study Locations
More Related Trials
-
Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)
NCT00761150 ·Status: COMPLETED ·Phase: PHASE3
-
Slow Opioid Tapering Pilot Study of Patients Using Chronic Opioid Therapy
NCT05297396 ·Status: COMPLETED ·Phase: NA
-
A Study of Pain Relief in Low Back Pain
NCT00325949 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Effectiveness and Safety of Tapentadol (CG5503) Extended Release (ER) in Patients With Moderate to Severe Chronic Low Back Pain
NCT00449176 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
NCT01789970 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Hydrocodone Bitartrate (HYD) in Subjects With Moderate to Severe Chronic Low Back Pain
NCT01452529 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate 90-Day Safety of Tapentadol(CG5503) Immediate Release (IR) or Oxycodone Immediate Release in Patients With Chronic Pain
NCT00364546 ·Status: COMPLETED ·Phase: PHASE3
-
Long-Term Safety and Tolerability Study of NKTR-181 in Subjects With Chronic Low Back Pain or Chronic Non-Cancer Pain
NCT02367820 ·Status: COMPLETED ·Phase: PHASE3
-
Evolution of Analgesic Tolerance With Opioids
NCT00275249 ·Status: COMPLETED ·Phase: NA
-
Open-Label Trial Comparing Oxycodone Medications
NCT01162304 ·Status: TERMINATED ·Phase: PHASE4
-
Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component.
NCT01838616 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Increasing Doses of Tapentadol Versus a Combination of Tapentadol and Pregabalin
NCT01352741 ·Status: COMPLETED ·Phase: PHASE4
-
Adjunctive Mindfulness During Opioid Tapering for patientS With Chronic Pain (The AMOS Study)
NCT06268522 ·Status: COMPLETED ·Phase: NA
-
Phase 1 Pharmacokinetic Study of Tapentadol Prolonged-Release 250 Milligram (mg) Formulation in Healthy Participants
NCT01877226 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
NCT01901328 ·Status: TERMINATED ·Phase: PHASE3
-
Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics
NCT00983385 ·Status: COMPLETED ·Phase: PHASE3
-
Lexington Observational Study of Treatment With Compounded Pain Creams
NCT02195752 ·Status: TERMINATED
-
Patient-Centered Opioid Tapering Study
NCT03303209 ·Status: COMPLETED
-
Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) for Relief of Moderate to Severe Pain in Patients With Osteoarthritis or Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
NCT01240863 ·Status: COMPLETED ·Phase: PHASE3
-
Celebrex vs Tramadol in the Treatment of Chronic Lower Back Pain.
NCT00290901 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Relative Bioavailability and Food Effect of a New Tablet Formulation of VX-548
NCT05455502 ·Status: COMPLETED ·Phase: PHASE1
-
taPentadol cLinical prAcTice IN belgiUM
NCT03814993 ·Status: COMPLETED
-
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
NCT01901302 ·Status: TERMINATED ·Phase: PHASE3
-
Safety and Tolerability of Egalet-002 in Patients With Moderate-to-Severe Chronic Noncancer Pain
NCT02603705 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of CG5503 Prolonged Release (PR) in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee
NCT00486811 ·Status: COMPLETED ·Phase: PHASE3